| 1 | * D.3.6.2.1 - valore : Every 4 weeks dosing of 200 mg | - | - | - | - | [1] 41 41 💬
|
| 2 | * D.3.6.2.1 - valore :Every 4 weeks dosing of 400 mg | - | - | - | - | [1] 41 41 💬
|
| 3 | 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione | - | - | - | - | [1] 41 41 💬
|
| 4 | 18FDG PET scan | - | - | - | - | [1] 41 41 💬
|
| 5 | [18F]PEG-Folate | - | - | - | - | [2] 41 41, 46 💬
|
| 6 | [ABT-494] | - | - | - | - | [7] 41 41, 46, 49, 96, 97, 107, 271 💬
|
| 7 | [AIN457] | - | - | - | - | [2] 41 41, 107 💬
|
| 8 | [CNTO1959] | - | - | - | - | [4] 37 37, 41, 96, 97 💬
|
| 9 | [NA] | - | - | - | - | [34] 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 10 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [28] 2 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
|
| 11 | ABT-494 | - | - | - | - | [7] 41 41, 46, 49, 96, 97, 107, 271 💬
|
| 12 | Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 19 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
|
| 13 | Additional blood samples | - | - | - | - | [1] 41 41 💬
|
| 14 | AIN457 | - | - | - | - | [9] 13 13, 37, 41, 46, 56, 96, 97, 107, 271 💬
|
| 15 | Alendronate versus alfacalcidol (1-alpha OH vitamin D) | [2] Alfacalcidol Alfacalcidol, Vitamin D | [1] Alfacalcidol
Alfacalcidol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [3] 41 41, 46, 50 💬
|
| 16 | Alfacalcidol | [1] Alfacalcidol Alfacalcidol | [1] Alfacalcidol
Alfacalcidol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [10] 41 41, 46, 49, 50, 96, 107, 222, 223, 235, 238 💬
|
| 17 | Anakinra | [1] Anakinra Anakinra | [1] Anakinra
Anakinra
💬
| [2] IL1R1 IL1R1, IL1R2 💬
| [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [22] 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
|
| 18 | Anti-Thymocyte Globulin | - | - | - | - | [19] 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
|
| 19 | Autologous peripheral blood stem cell transplantation | - | - | - | - | [9] 28 28, 40, 41, 42, 45, 46, 49, 63, 283 💬
|
| 20 | AzaFol | - | - | - | - | [1] 41 41 💬
|
| 21 | Baricitinib | [1] Baricitinib Baricitinib | [1] Baricitinib
Baricitinib
💬
| [2] JAK1 JAK1, JAK2 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [24] 2 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
|
| 22 | Blood samples | - | - | - | - | [14] 13 13, 41, 46, 49, 51, 61, 63, 96, 97, 160, 167, 227, 240, 271 💬
|
| 23 | Bosentan | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
,
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [12] 13 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
| 24 | Bosentan and dapagliflozin | [2] Bosentan Bosentan, Dapagliflozin | [3] Bosentan
Bosentan
,
Bosentan
,
Dapagliflozin
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 40 40, 41 💬
|
| 25 | BOSENTAN MYLAN | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
,
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 41 41 💬
|
| 26 | Capsule di prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 27 | CNTO 136 | - | - | - | - | [2] 41 41, 46 💬
|
| 28 | CNTO1959 | - | - | - | - | [4] 37 37, 41, 96, 97 💬
|
| 29 | Combination Product: mavrilimumab | [1] Mavrilimumab Mavrilimumab | [1] Mavrilimumab
Mavrilimumab
💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 41 41 💬
|
| 30 | CORTANCYL | - | - | - | - | [1] 41 41 💬
|
| 31 | Cortancyl ® 1 mg | - | - | - | - | [1] 41 41 💬
|
| 32 | Cortancyl ® 20 mg | - | - | - | - | [1] 41 41 💬
|
| 33 | Cortancyl ® 5 mg | - | - | - | - | [1] 41 41 💬
|
| 34 | Corticoids+ tocilizumab 8mg/Kg/4 weeks | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬
|
| 35 | Corticosteroid (CS) | - | - | - | - | [1] 41 41 💬
|
| 36 | Corticosteroids | - | - | - | - | [13] 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 222, 223, 296, 300 💬
|
| 37 | Corticosteroids for Systemic Use | - | - | - | - | [1] 41 41 💬
|
| 38 | Cosentyx | - | - | - | - | [4] 41 41, 107, 269, 271 💬
|
| 39 | Cosentyx 300 mg solution for injection in pre-filled syringe | - | - | - | - | [1] 41 41 💬
|
| 40 | Cosentyx 300mg solution for injection in pre-filled syringe | - | - | - | - | [1] 41 41 💬
|
| 41 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [50] 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 42 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [39] 11 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
|
| 43 | Dapagliflozin | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [16] 6 6, 19, 28, 40, 41, 49, 57, 66, 67, 86, 88, 97, 210, 215, 218, 222 💬
|
| 44 | Diagnostic Test: 3'mRNA sequencing | - | - | - | - | [1] 41 41 💬
|
| 45 | Diagnostic Test: 3D T1 MRI sequences injected with fat saturation and black blood | - | - | - | - | [1] 41 41 💬
|
| 46 | Diagnostic Test: 68-Ga HA-DOTATATE PET/CT | [1] Dotatate Dotatate | - | - | - | [1] 41 41 💬
|
| 47 | Diagnostic Test: Analysis of blood and microbiome samples (stool, oral lavage) | - | - | - | - | [1] 41 41 💬
|
| 48 | Diagnostic Test: Angio-Optical Coherence Tomography | - | - | - | - | [1] 41 41 💬
|
| 49 | Diagnostic Test: Aortic/ cardiac magnetic resonance imaging | - | - | - | - | [1] 41 41 💬
|
| 50 | Diagnostic Test: Cell-based ex-vivo assay with high-content analysis | - | - | - | - | [1] 41 41 💬
|
| 51 | Diagnostic Test: Color Fundus Photography | - | - | - | - | [1] 41 41 💬
|
| 52 | Diagnostic Test: Contrast-Enhanced Ultrasound | - | - | - | - | [1] 41 41 💬
|
| 53 | Diagnostic Test: Enzyme-linked immunosorbent assay | - | - | - | - | [1] 41 41 💬
|
| 54 | Diagnostic Test: Flow cytometry | - | - | - | - | [1] 41 41 💬
|
| 55 | Diagnostic Test: Fluorescein and Indocyanine green Angiography | [3] Fluorescein Fluorescein, Indocyanine green, Indocyanine green acid form | [3] Fluorescein
Fluorescein
,
Indocyanine green
,
Fluorescein sodium
💬
| - | - | [1] 41 41 💬
|
| 56 | Diagnostic Test: Fluorescein angiography | [1] Fluorescein Fluorescein | [2] Fluorescein
Fluorescein
,
Fluorescein sodium
💬
| - | - | [1] 41 41 💬
|
| 57 | Diagnostic Test: Functional assessment questionnaires | - | - | - | - | [1] 41 41 💬
|
| 58 | Diagnostic Test: Fundus autofluorescence | - | - | - | - | [1] 41 41 💬
|
| 59 | Diagnostic Test: High-resolution Optical Coherence Tomography | - | - | - | - | [1] 41 41 💬
|
| 60 | Diagnostic Test: Immunohistochemistry of Temporal Artery Biopsies | - | - | - | - | [1] 41 41 💬
|
| 61 | Diagnostic Test: Laboratory assessment: | - | - | - | - | [1] 41 41 💬
|
| 62 | Diagnostic Test: Optical coherence tomography angiography | - | - | - | - | [1] 41 41 💬
|
| 63 | Diagnostic Test: Transorbital Ultrasound | - | - | - | - | [1] 41 41 💬
|
| 64 | Diagnostic Test: Vascular ultrasound | - | - | - | - | [1] 41 41 💬
|
| 65 | Diagnostic Test: Zirconium Zr 89 labelled rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 41 41 💬
|
| 66 | Discontinue Tocilizumab | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬
|
| 67 | Dotatate | [1] Dotatate Dotatate | - | - | - | [5] 19 19, 41, 75, 84, 238 💬
|
| 68 | Encorton | - | - | - | - | [1] 41 41 💬
|
| 69 | FDG | - | - | - | - | [2] 41 41, 84 💬
|
| 70 | Filgrastim | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [30] 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
| 71 | Fluorescein | [1] Fluorescein Fluorescein | [2] Fluorescein
Fluorescein
,
Fluorescein sodium
💬
| - | - | [4] 19 19, 22, 41, 97 💬
|
| 72 | FLUORINE-18 | - | - | - | - | [1] 41 41 💬
|
| 73 | Gevokizumab | [1] Gevokizumab Gevokizumab | [1] Gevokizumab
Gevokizumab
💬
| [1] IL1B IL1B 💬
| [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [4] 41 41, 50, 56, 269 💬
|
| 74 | Glucocorticoid Treatment | - | - | - | - | [1] 41 41 💬
|
| 75 | Glucocorticoids | - | - | - | - | [13] 35 35, 40, 41, 43, 44, 49, 60, 61, 62, 75, 96, 221, 300 💬
|
| 76 | GSK2973327 | - | - | - | - | [1] 41 41 💬
|
| 77 | GUSELKUMAB | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [7] 37 37, 41, 51, 96, 97, 161, 269 💬
|
| 78 | H02AB09 | - | - | - | - | [1] 41 41 💬
|
| 79 | Hydrocortisone | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [10] 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬
|
| 80 | Hydrokortison | - | - | - | - | [1] 41 41 💬
|
| 81 | Hydrokortison orion | - | - | - | - | [1] 41 41 💬
|
| 82 | Hydroxychloroquine | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [29] 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
|
| 83 | Indocyanine green | [2] Indocyanine green Indocyanine green, Indocyanine green acid form | [1] Indocyanine green
Indocyanine green
💬
| - | - | [9] 22 22, 41, 46, 51, 96, 235, 278, 291, 296 💬
|
| 84 | Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [27] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
|
| 85 | Kevzara ® | - | - | - | - | [1] 41 41 💬
|
| 86 | KINERET | - | - | - | - | [8] 41 41, 49, 54, 57, 65, 106, 266, 299 💬
|
| 87 | KPL-301 | - | - | - | - | [1] 41 41 💬
|
| 88 | L04AC07 | - | - | - | - | [2] 41 41, 46 💬
|
| 89 | Lodotra | - | - | - | - | [1] 41 41 💬
|
| 90 | Lodotra (delayed release prednisolone) | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 91 | MAVRILIMUMAB | [1] Mavrilimumab Mavrilimumab | [1] Mavrilimumab
Mavrilimumab
💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [2] 41 41, 46 💬
|
| 92 | Methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [41] 11 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 93 | Methotrexate treatment | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [2] 41 41, 46 💬
|
| 94 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [51] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 95 | METOJECT | - | - | - | - | [6] 41 41, 46, 96, 97, 107, 271 💬
|
| 96 | Naltrexone | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [14] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
|
| 97 | NALTREXONE HYDROCHLORIDE | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [9] 10 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
|
| 98 | Nivolumab | [1] Nivolumab Nivolumab | [1] Nivolumab
Nivolumab
💬
| [1] PDCD1 PDCD1 💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [12] 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
| 99 | Other: 18F-FDG PET/CT | - | - | - | - | [1] 41 41 💬
|
| 100 | Other: Blood sample | - | - | - | - | [37] 2 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
|
| 101 | Other: Data collection for cellular analyses (Immune subset composition, GCR expression, in vitro steroid responsiveness) | - | - | - | - | [1] 41 41 💬
|
| 102 | Other: Data collection for correlation between clinical defined and lab defined GC responsivness | - | - | - | - | [1] 41 41 💬
|
| 103 | Other: Data collection for exploratory analyses of endogenous steroid hormones | - | - | - | - | [1] 41 41 💬
|
| 104 | Other: Data collection for Prednisone metabolism | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 105 | Other: IV steroids combination alone | - | - | - | - | [1] 41 41 💬
|
| 106 | Other: Questionnaires | - | - | - | - | [8] 3 3, 6, 13, 41, 46, 77, 96, 226 💬
|
| 107 | Other: Usual medical management of patients, additional blood and stool samples for biobanking | - | - | - | - | [6] 40 40, 41, 46, 48, 53, 56 💬
|
| 108 | Over encapsulated prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 109 | PET10 | - | - | - | - | [1] 41 41 💬
|
| 110 | PET3 | - | - | - | - | [1] 41 41 💬
|
| 111 | Pr | - | - | - | - | [1] 41 41 💬
|
| 112 | Prednisolon 1 mg JENAPHARM | - | - | - | - | [1] 41 41 💬
|
| 113 | Prednisolon 10 mg JENAPHARM | - | - | - | - | [1] 41 41 💬
|
| 114 | Prednisolon 20 mg JENAPHARM | - | - | - | - | [1] 41 41 💬
|
| 115 | Prednisolon 5 mg JENAPHARM | - | - | - | - | [1] 41 41 💬
|
| 116 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 117 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 118 | Prednisone and ustekinumab treatment | [2] Prednisone Prednisone, Ustekinumab | [2] Prednisone
Prednisone
,
Ustekinumab
💬
| [4] IL12A IL12A, IL12B, IL23A, NR3C1 💬
| [29] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 41 41 💬
|
| 119 | Prednisone Capsule | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 120 | Prednisone Capsules | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 121 | PredniSONE Tablets USP, 1 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 41 41, 46 💬
|
| 122 | PredniSONE Tablets USP, 10 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 123 | PredniSONE Tablets USP, 1mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 124 | PredniSONE Tablets USP, 2.5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 125 | PredniSONE Tablets USP, 2.5mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 126 | PredniSONE Tablets USP, 20mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 127 | PredniSONE Tablets USP, 5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 41 41, 46 💬
|
| 128 | PredniSONE Tablets USP, 5mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 129 | PredniSONE Tablets, USP | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 41 41, 43, 44 💬
|
| 130 | PredniSONE Tablets, USP 10 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 131 | PredniSONE Tablets, USP 2.5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 132 | PredniSONE Tablets, USP 5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 133 | PredniSONE Tablets, USP, 1 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 134 | Prednisone therapy and pharmacokinetic | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 135 | Prednisone treatment | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 136 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 137 | Ro 001-9265 | - | - | - | - | [1] 41 41 💬
|
| 138 | Ro 001-9265/F02 | - | - | - | - | [1] 41 41 💬
|
| 139 | Ro 001-9265/F03 | - | - | - | - | [1] 41 41 💬
|
| 140 | Ro 001-9265/F04 | - | - | - | - | [1] 41 41 💬
|
| 141 | Ro 487-7533/F10-04 | - | - | - | - | [4] 41 41, 46, 51, 107 💬
|
| 142 | RoActemra | - | - | - | - | [7] 41 41, 44, 46, 51, 86, 107, 271 💬
|
| 143 | RoActemra 162 mg solution for injection in pre-filled syringe | - | - | - | - | [1] 41 41 💬
|
| 144 | RoActemre | - | - | - | - | [1] 41 41 💬
|
| 145 | S78989 | - | - | - | - | [3] 41 41, 50, 56 💬
|
| 146 | SARILUMAB | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [5] 41 41, 46, 84, 107, 271 💬
|
| 147 | Sarilumab SAR153191 | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬
|
| 148 | SECUKINUMAB | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [9] 13 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
|
| 149 | Secukinumab 150 mg | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 💬
|
| 150 | Secukinumab 300 mg | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 💬
|
| 151 | Secukinumab 300 mg, s.c. | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 💬
|
| 152 | Shingrix | - | - | - | - | [6] 41 41, 46, 49, 51, 96, 97 💬
|
| 153 | Sirukumab | [1] Sirukumab Sirukumab | [1] Sirukumab
Sirukumab
💬
| [1] IL6 IL6 💬
| [49] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [2] 41 41, 46 💬
|
| 154 | Sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [31] 2 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
|
| 155 | Tocilizumab | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [26] 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
|
| 156 | Tocilizumab + Glucocorticoids (GCs) | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬
|
| 157 | Tocilizumab 162Mg/0.9Ml Autoinjector | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬
|
| 158 | Tocilizumab and IV steroids combination | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬
|
| 159 | Tocilizumab Prefilled Syringe | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 41 41, 46 💬
|
| 160 | TOCILIZUMAB SC | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [3] 41 41, 46, 107 💬
|
| 161 | Tocilizumab treatment | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬
|
| 162 | Treatment | - | - | - | - | [2] 41 41, 299 💬
|
| 163 | Upadacitinib | [1] Upadacitinib Upadacitinib | [3] Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [12] 40 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
|
| 164 | Ustekinumab | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [17] 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
|
| 165 | Vaccination with 2 doses of Shingrix vaccine | - | - | - | - | [2] 41 41, 51 💬
|
| 166 | Vitamin D | [1] Vitamin D Vitamin D | - | - | - | [26] 3 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
|
| 167 | XOMA 052 | - | - | - | - | [5] 41 41, 46, 50, 56, 106 💬
|